Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2009
SPECT in acute pulmonary embolism
Paul D Stein, Leonard M Freeman, H Dirk Sostman, et al.
British Journal of Cancer
|
November 26, 2022
Dual [<sup>68</sup>Ga]DOTATATE and [<sup>18</sup>F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
David L Chan, Aimee R Hayes, Ioannis Karfis, et al.
JAMA Oncology
|
July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
Simron Singh, Lesley Moody, David L Chan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial
David L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Molecular Imaging and Biology
|
March 27, 2014
Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany
Dale L Bailey, Henryk Barthel, Bettina Beuthin-Baumann, et al.
Physics in Medicine and Biology
|
December 18, 2020
Quantitative PET in the 2020s: a roadmap
Steven R Meikle, Vesna Sossi, Emilie Roncali, et al.
BMJ Open
|
August 4, 2023
[<sup>18</sup>F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial
Eng-Siew Koh, Hui K Gan, Clare Senko, et al.
The Lancet. Oncology
|
July 3, 2026
Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)
Christophe M Deroose, Hannes Leupe, Rodney J Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative
Akram Al-Ibraheem, Andrew M Scott, Ahmed Saad Abdlkadir, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2009
SPECT in acute pulmonary embolism
Paul D Stein, Leonard M Freeman, H Dirk Sostman, et al.
British Journal of Cancer
|
November 26, 2022
Dual [<sup>68</sup>Ga]DOTATATE and [<sup>18</sup>F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
David L Chan, Aimee R Hayes, Ioannis Karfis, et al.
JAMA Oncology
|
July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
Simron Singh, Lesley Moody, David L Chan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial
David L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Molecular Imaging and Biology
|
March 27, 2014
Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany
Dale L Bailey, Henryk Barthel, Bettina Beuthin-Baumann, et al.
Physics in Medicine and Biology
|
December 18, 2020
Quantitative PET in the 2020s: a roadmap
Steven R Meikle, Vesna Sossi, Emilie Roncali, et al.
BMJ Open
|
August 4, 2023
[<sup>18</sup>F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial
Eng-Siew Koh, Hui K Gan, Clare Senko, et al.
The Lancet. Oncology
|
July 3, 2026
Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)
Christophe M Deroose, Hannes Leupe, Rodney J Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative
Akram Al-Ibraheem, Andrew M Scott, Ahmed Saad Abdlkadir, et al.
Page
of 14